Somnolence: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 40: | Line 40: | ||
* [[Lyme disease]] (borreliosis) | * [[Lyme disease]] (borreliosis) | ||
* [[Medications]] | * [[Medications]] | ||
** [[Analgesics]]: mostly prescribed or illicit [[opiates]] such as [[ | ** [[Analgesics]]: mostly prescribed or illicit [[opiates]] such as [[oxycontin]] or [[heroin]] | ||
** [[Antiepileptic]]s such as [[phenytoin]], [[carbamazepine]], [[gabapentin]] | ** [[Antiepileptic]]s such as [[phenytoin]], [[carbamazepine]], [[gabapentin]] | ||
** [[Antidepressants]]: for instance sedating [[tricyclic antidepressants]]<ref name="pmid16832696">{{cite journal |author=Zimmermann C, Pfeiffer H |title=[Sleep disorders in depression. Suggestions for a therapeutic approach] |language=German |journal=Nervenarzt |volume=78 |issue=1 |pages=21–30 |date=January 2007 |pmid=16832696 |doi=10.1007/s00115-006-2111-1 |url=}}</ref> and [[mirtazapine]]. Somnolence is less common with [[SSRI]]<ref name="pmid22161405">{{cite journal |author=Watanabe N, Omori IM, Nakagawa A, ''et al.'' |title=Mirtazapine versus other antidepressive agents for depression |journal=Cochrane Database Syst Rev |volume= |issue=12 |pages=CD006528 |year=2011 |pmid=22161405 |doi=10.1002/14651858.CD006528.pub2 |url=}}</ref> and [[SNRI]] as well as [[MAOI]]. | ** [[Antidepressants]]: for instance sedating [[tricyclic antidepressants]]<ref name="pmid16832696">{{cite journal |author=Zimmermann C, Pfeiffer H |title=[Sleep disorders in depression. Suggestions for a therapeutic approach] |language=German |journal=Nervenarzt |volume=78 |issue=1 |pages=21–30 |date=January 2007 |pmid=16832696 |doi=10.1007/s00115-006-2111-1 |url=}}</ref> and [[mirtazapine]]. Somnolence is less common with [[SSRI]]<ref name="pmid22161405">{{cite journal |author=Watanabe N, Omori IM, Nakagawa A, ''et al.'' |title=Mirtazapine versus other antidepressive agents for depression |journal=Cochrane Database Syst Rev |volume= |issue=12 |pages=CD006528 |year=2011 |pmid=22161405 |doi=10.1002/14651858.CD006528.pub2 |url=}}</ref> and [[SNRI]] as well as [[MAOI]]. | ||
| Line 47: | Line 47: | ||
** [[Dopamine agonists]] used in the treatment of [[parkinson's disease]] e.g. [[pergolide]], ropinirole and [[pramipexole]]. | ** [[Dopamine agonists]] used in the treatment of [[parkinson's disease]] e.g. [[pergolide]], ropinirole and [[pramipexole]]. | ||
** [[HIV]] medications – for example, [[efavirenz]] | ** [[HIV]] medications – for example, [[efavirenz]] | ||
** [[ | ** [[Antihypertensive]] medications like [[amlodipine]] | ||
** [[Hypnotics]] like [[zopiclone]], or the [[benzodiazepine]] such as [[diazepam]] or [[nitrazepam]] and the [[barbiturate]], such as [[amobarbital]] or [[secobarbital]] | ** [[Hypnotics]] like [[zopiclone]], or the [[benzodiazepine]] such as [[diazepam]] or [[nitrazepam]] and the [[barbiturate]], such as [[amobarbital]] or [[secobarbital]] | ||
** other agents impacting the [[central nervous system]] in sufficient or toxic doses, | ** other agents impacting the [[central nervous system]] in sufficient or toxic doses, | ||
Revision as of 23:06, 9 March 2014
For patient information, click here
| Somnolence | |
| ICD-10 | R40.0 |
|---|---|
| ICD-9 | 780.09 |
Template:Search infobox Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Somnolence (or "drowsiness") is a state of near-sleep, a strong desire for sleep, or sleeping for unusually long periods. It has two distinct meanings, referring both to the usual state preceding falling asleep, and the chronic condition referring to being in that state independent of a circadian rhythm. The disorder characterized by the latter condition is most commonly associated with users of prescription hypnotics, such as mirtazapine or zolpidem.
It is considered a lesser impairment of consciousness than stupor or coma.
Hazards
Somnolence can be dangerous when performing tasks that require constant concentration, such as driving a vehicle. When a person is sufficiently fatigued, he or she may experience microsleeps (loss of concentration).
Associated conditions
- Advanced sleep phase disorder
- Alice in Wonderland syndrome
- brain edema
- Cerebral hypoxia
- Chronic fatigue syndrome
- Clinical depression, especially seasonal affective disorder (SAD)
- Dehydration
- Delayed sleep phase syndrome
- Diabetes ketoacidosis as example, but not balanced diabetes mellitus
- Encephalitis – (viral, bacterial or other agents)
- Epilepsy – after seizure
- Fibromyalgia
- Hydrocephalus
- Hyperparathyroidism
- Hypothermia
- Hypothyroidism
- Idiopathic hypersomnia
- Infectious mononucleosis (glandular fever)
- Intracranial hemorrhage such as due to ruptured aneurysm
- Increased intracranial pressure; for example, due to brain tumors
- Lyme disease (borreliosis)
- Medications
- Analgesics: mostly prescribed or illicit opiates such as oxycontin or heroin
- Antiepileptics such as phenytoin, carbamazepine, gabapentin
- Antidepressants: for instance sedating tricyclic antidepressants[1] and mirtazapine. Somnolence is less common with SSRI[2] and SNRI as well as MAOI.
- Antihistamines: diphenhydramine and doxylamine
- Antipsychotics: thioridazine, quetiapine, olanzapine, risperidone, and ziprasidone but not haloperidol
- Dopamine agonists used in the treatment of parkinson's disease e.g. pergolide, ropinirole and pramipexole.
- HIV medications – for example, efavirenz
- Antihypertensive medications like amlodipine
- Hypnotics like zopiclone, or the benzodiazepine such as diazepam or nitrazepam and the barbiturate, such as amobarbital or secobarbital
- other agents impacting the central nervous system in sufficient or toxic doses,
- Narcolepsy
- Sickness behavior
- Sleep apnea
- Insomnia
- Starvation
- Stroke
- Traumatic brain injury
- African trypanosomiasis ("sleeping sickness")
See also
- Template:Wiktionary inline
- Chronic Fatigue Syndrome
- Decision fatigue
- fibromyalgia
- Insomnia
- Hypersomnia
- Dyssomnia
- Fatigue (physical)
- Postprandial somnolence
- Restless legs syndrome
- Periodic limb movement
References
- ↑ Zimmermann C, Pfeiffer H (January 2007). "[Sleep disorders in depression. Suggestions for a therapeutic approach]". Nervenarzt (in German). 78 (1): 21–30. doi:10.1007/s00115-006-2111-1. PMID 16832696.
- ↑ Watanabe N, Omori IM, Nakagawa A; et al. (2011). "Mirtazapine versus other antidepressive agents for depression". Cochrane Database Syst Rev (12): CD006528. doi:10.1002/14651858.CD006528.pub2. PMID 22161405.
Template:Cognition, perception, emotional state and behaviour symptoms and signs Template:SleepSeries2